{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-134882","form_type":"8-K","ticker":"STOK","cik":"0001623526","company_name":"Stoke Therapeutics, Inc.","filed_at":"2025-06-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.095076+00:00","generated_at":"2026-05-19T23:57:15.158930+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Stoke Therapeutics shareholders elect three Class III directors at 2025 annual meeting","bullets":["Edward M. Kaye, Seth L. Harrison, and Arthur O. Tzianabos elected as Class III directors with ~29.2M votes each.","Ratification of KPMG as independent auditor for FY2025 approved with 38.7M for vs 67.8K against.","Non-binding advisory vote on named executive officer compensation approved with 30.5M for vs 2.9M against.","Advisory vote on frequency of future say-on-pay set at one year (33.1M votes) as preferred frequency."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-134882","json":"https://secwatch.observer/filing/0001193125-25-134882.json","markdown":"https://secwatch.observer/filing/0001193125-25-134882.md","text":"https://secwatch.observer/filing/0001193125-25-134882.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1623526/000119312525134882/0001193125-25-134882-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1623526/000119312525134882/d936696d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T23:57:15.158930+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}